KRAS and cancer: We also showed that U0126, a MAP kinase (MEK) inhibitor, could suppress the pro-proliferative effects of oncogenic KRAS, suggesting zebrafish could potentially be used as in vivo models to screening for Ras inhibitors that may prove to be of therapeutic value to a variety of human cancers with activated RAS signaling, including certain types of brain tumors.